Literature DB >> 1204242

Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

F Paronetto, S Vernace.   

Abstract

The cytotoxic activity of lymphocytes against autochthonous liver cells was studied in patients with chronic liver diseases and in controls. Cytotoxicity of lymphocytes was observed in eight of ten patients with chronic active hepatitis, two patients with chronic persistent hepatitis, one patient with primary biliary cirrhosis, one patient with alcoholic hepatitis and carcinoma of the pancreas, and in three of five patients with acute viral hepatitis, but not in seven patients without liver alteration or with miscellaneous liver diseases. Serum was not cytotoxic, but in three patients it decreased the cytotoxicity of lymphocytes. Cytotoxicity was seen in both HBAg-positive and HBAg-negative patients, appears to be influenced by therapy, and does not correlate with autoantibodies. These data support the hypothesis of an aggressive activity of lymphocytes in certain liver diseases.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1204242      PMCID: PMC1538041     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Cell-mediated immune reactivity in liver disease.

Authors:  P A Bacon; H Berry; R Bown
Journal:  Gut       Date:  1972-06       Impact factor: 23.059

2.  Immunologic aspects of liver disease.

Authors:  F Paronetto
Journal:  Postgrad Med       Date:  1973-01       Impact factor: 3.840

3.  Lymphocyte transformation and alcoholic liver injury.

Authors:  M F Sorrell; C M Leevy
Journal:  Gastroenterology       Date:  1972-12       Impact factor: 22.682

4.  Tisstue culture of adult human liver.

Authors:  C F Demoise; J T Galambos; A Falek
Journal:  Gastroenterology       Date:  1971-03       Impact factor: 22.682

5.  Production of plasma proteins by subcultures of adult human liver.

Authors:  Y Le Guilly; P Lenoir; M Bourel
Journal:  Biomedicine       Date:  1973-08-10

6.  Cell-mediated immune responses in chronic liver diseases.

Authors:  M G Smith; P L Golding; A L Eddleston; C G Mitchell; A Kemp; R Williams
Journal:  Br Med J       Date:  1972-02-26

7.  Ribosome biosynthesis in cultured lymphocytes: II. The role of ribosomal RNA production in the initiation and maintenance of lymphocyte growth.

Authors:  A D Rubin
Journal:  Blood       Date:  1970-05       Impact factor: 22.113

8.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

9.  Immunologic studies in patients with chronic active hepatitis and primary biliary cirrhosis. I. Cytotoxic activity and binding of sera to human liver cells grown in tissue culture.

Authors:  F Paronetto; M Gerber; S J Vernace
Journal:  Proc Soc Exp Biol Med       Date:  1973-07

10.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

View more
  35 in total

1.  Flow cytometric and functional analysis of mononuclear cells infiltrating the liver in experimental autoimmune hepatitis.

Authors:  H Kohda; C Sekiya; M Kanai; Y Yoshida; T Uede; K Kikuchi; M Namiki
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.

Authors:  K Thestrup-Pedersen; K Ladefoged; P Andersen
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

3.  T and B lymphocytes in patients with chronic active hepatitis (CAH).

Authors:  M Colombo; S J Vernace; F Paronetto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

4.  Reduction in peripheral blood K cells and activated T cells in primary biliary cirrhosis.

Authors:  G P Sandilands; R N Macsween; K G Gray; R J Holden; P Mills; F M Reid; M A Thomas; G Watkinson
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

5.  Lymphocyte-mediated cytotoxicity in isoniazid-associated hepatitis.

Authors:  R J Warrington; S L Olivier
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

6.  Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease.

Authors:  J Sanchez-Tapias; H C Thomas; S Sherlock
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

7.  Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.

Authors:  E Fernandez-Cruz; P Escartin; A Bootello; M Kreisler; J M Segovia de Arana
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

8.  Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).

Authors:  H Warnatz; W Rösch; W Gerlich; W Gutmann
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

9.  Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.

Authors:  P Tolentino; C Jannuzzi; R Giacchino
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

10.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.

Authors:  G Mieli-Vergani; D Vergani; B Portmann; Y White; I Murray-Lyon; J H Marigold; I Woolf; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.